GlassScriptPhysician profile
Elizabeth A Guancial
NPI 1124155569
$3,781.21
in general payments reported to CMS, 2019-2025
47 companies · $740 in 2025
The $740 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $271 · 2022: $332 · 2023: $724 · 2024: $471 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,936.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,935.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $321.38 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $255.47 | 2019-2023 | Keytruda |
| Genzyme Corporation | $221.68 | 2019-2025 | |
| Gilead Sciences, INC. | $215.02 | 2019-2025 | Trodelvy |
| Novartis Pharmaceuticals Corporation | $194.88 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $193.37 | 2020-2023 | Calquence |
| Astellas Pharma US INC | $165.71 | 2019-2025 | Padcev, Xospata, Vyloy |
| Celgene Corporation | $148.76 | 2022-2025 | Reblozyl, Opdualag |
| Array Biopharma INC | $148.20 | 2019-2025 | Lorbrena, Braftovi, Mektovi |
| Hologic Sales and Service, LLC | $147.21 | 2025 | Sentimag, Magtrace |
| Pfizer INC. | $139.07 | 2019-2025 | |
| Intuitive Surgical, INC. | $134.61 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $126.96 | 2019 | |
| Lilly USA, LLC | $108.45 | 2019-2023 | Jaypirca, Verzenio |
| Daiichi Sankyo INC. | $101.24 | 2023 | Enhertu |
Show all 41 companies
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Guancial listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.